Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study
- DOI
- 10.1097/cmr.0000000000000888
- Published
- 2023-03-28
- Container
- Melanoma Research
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/cmr.0000000000000888,
title = {Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study},
author = {José L. Manzano and Juan Martin-Liberal and Luis A. Fernández-Morales and Gretel Benítez and Javier Medina Martínez and María Quindós and Almudena García-Castaño and Ovidio Fernández and Rocío V. Simo and Margarita Majem and Lorena Bellido and Pablo Ayala de Miguel and Begoña Campos and Enrique Espinosa and José A. Macías Cerrolaza and Irene Gil-Arnaiz and David Lorente and Alvaro Rodriguez-Lescure and Victor N. Perez and Rafael López Castro and María G. Gramaje and Teresa Puértolas and Juan F. Rodriguez Moreno and Laia Espasa Font and Guillermo Belaustegui Ferrández and Pablo Cerezuela-Fuentes},
year = {2023},
journal = {Melanoma Research},
doi = {10.1097/cmr.0000000000000888},
url = {https://doi.org/10.1097/cmr.0000000000000888}
}RIS
TY - JOUR TI - Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study AU - José L. Manzano AU - Juan Martin-Liberal AU - Luis A. Fernández-Morales AU - Gretel Benítez AU - Javier Medina Martínez AU - María Quindós AU - Almudena García-Castaño AU - Ovidio Fernández AU - Rocío V. Simo AU - Margarita Majem AU - Lorena Bellido AU - Pablo Ayala de Miguel AU - Begoña Campos AU - Enrique Espinosa AU - José A. Macías Cerrolaza AU - Irene Gil-Arnaiz AU - David Lorente AU - Alvaro Rodriguez-Lescure AU - Victor N. Perez AU - Rafael López Castro AU - María G. Gramaje AU - Teresa Puértolas AU - Juan F. Rodriguez Moreno AU - Laia Espasa Font AU - Guillermo Belaustegui Ferrández AU - Pablo Cerezuela-Fuentes PY - 2023 JO - Melanoma Research DO - 10.1097/cmr.0000000000000888 UR - https://doi.org/10.1097/cmr.0000000000000888 ER -
APA
Manzano, J. L., Martin-Liberal, J., Fernández-Morales, L. A., Benítez, G., Martínez, J. M., Quindós, M., García-Castaño, A., Fernández, O., Simo, R. V., Majem, M., Bellido, L., Miguel, P. A. D., Campos, B., Espinosa, E., Cerrolaza, J. A. M., Gil-Arnaiz, I., Lorente, D., Rodriguez-Lescure, A., Perez, V. N., Castro, R. L., Gramaje, M. G., Puértolas, T., Moreno, J. F. R., Font, L. E., Ferrández, G. B., & Cerezuela-Fuentes, P. (2023). Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study. Melanoma Research. https://doi.org/10.1097/cmr.0000000000000888
Source records
- crossref · retrieved 2026-09-27T00:01:52.042Z